肺癌第8版TNM分期解读与展望

doi:10.3969/j.issn.1006-7795.2016.06.007

首都医科大学学报 ›› 2016, Vol. 37 ›› Issue (6): 753-757.doi: 10.3969/j.issn.1006-7795.2016.06.007

肺癌第8版TNM分期解读与展望

刘宝东, 支修益

首都医科大学宣武医院胸外科, 北京 100053

收稿日期:2016-10-03 出版日期:2016-12-21 发布日期:2016-12-16
通讯作者: 支修益 E-mail:xiuyizhi2015@163.com
基金资助:
国家自然科学基金（81572704）

Interpretation and prospect of the eighth edition of TNM staging for lung cancer

Liu Baodong, Zhi Xiuyi

Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Received:2016-10-03 Online:2016-12-21 Published:2016-12-16
Supported by:
This study was supported by National Natural Science Foundation of China (81572704).

摘要/Abstract

摘要： 在过去的6年多时间里，肺癌的诊断和治疗研究取得了巨大的进步，但是第7版肺癌TNM分期难以满足目前的临床需求。于是国际肺癌研究协会（International Association for the Study of Lung Cancer，IASLC）收集了1999年至2010年间94 708例新确诊的肺癌患者，患者来自16个国家的35个中心，形成第8版肺癌TNM分期。第8版肺癌TNM分期较第7版TNM分期能够更好地反映不同分期患者的预后。

关键词: 肺癌, 肺癌分期, TNM分期

Abstract: Over the past six years, with the diagnosis and treatment of lung cancer has meaningful advances, the 7th edition of lung cancer TNM staging is difficult to meet the current clinical needs. Therefore, International Association for the Study of Lung Cancer (IASLC) has information on 94 708 new patients diagnosed as lung cancer originated from 35 sources in 16 countries between 1999 and 2010, forming the eighth edition of TNM staging of lung cancer. The new edition of the classification will then be enacted in January 2017. The advantages of the new staging has higher value in prognosis and clinical guidance of different patients.

Key words: lung cancer, lung cancer stage, TNM classification

中图分类号:

刘宝东, 支修益. 肺癌第8版TNM分期解读与展望[J]. 首都医科大学学报, 2016, 37(6): 753-757.

Liu Baodong, Zhi Xiuyi. Interpretation and prospect of the eighth edition of TNM staging for lung cancer[J]. Journal of Capital Medical University, 2016, 37(6): 753-757.

参考文献

[1] Mountain C F.Revisions in the international system for staging lungcancer[J].Chest,1997,111(6):1710-1717.
[2] UICC. TNM classification of malignant tumours[M]. Geneva: UICC, 1968.
[3] Groome P A,Bolejack V,Crowley J J,et al.The IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours[J]. J Thorac Oncol,2007,2(8):694-705.
[4] Rami-Porta R,Ball D,Crowley J,et al.The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2007,2(7):593-602.
[5] Rusch V W,Crowley J,Giroux D J,et al.The IASLC lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2007,2(7):603-612.
[6] Postmus P E,Brambilla E,Chansky K,et al.The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer[J]. J Thorac Oncol,2007,2(8):686-693.
[7] Goldstraw P,Crowley J,Chansky K,et al.The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours[J]. J Thorac Oncol,2007,2(8):706-714.
[8] Rami-Porta R,Bolejack V,Giroux D J,et al.The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer[J]. J Thorac Oncol,2014,9(11):1618-1624.
[9] Rami-Porta R,Bolejack V,Crowley J,et al.The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2015,10(7);990-1003.
[10] Eberhardt W E,Mitchell A,Crowley J,et al.The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer[J]. J Thorac Oncol,2015,10(11):1515-1522.
[11] Nicholson A G,Chansky K,Crowley J,et al.The International association for the study of lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2016, 11(3):300-311.
[12] Goldstraw P,Chansky K,Crowley J,et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2016,11(1):39-51.
[13] Detterbeck F C,Marom E M,Arenberg D A,et al.The IASLC lung cancer staging project: background data and proposals for the application of TNM staging rules to lung cancer presenting as multiple nodules with ground glass or lepidic features or a pneumonic type of involvement in the forthcoming eighth edition of the TNM classification[J]. J Thorac Oncol,2016,11(5):666-680.
[14] Detterbeck F C,Nicholson A G,Franklin W A,et al. The IASLC lung cancer staging project: summary of proposals for revisions of the classification of lung cancers with multiple pulmonary sites of involvement in the forthcoming eighth edition of the TNM classification[J]. J Thorac Oncol,2016,11(5):639-650.
[15] Detterbeck F C,Bolejack V,Arenberg D A,et al.The IASLC lung cancer staging project: background data and proposals for the classification of lung cancer with separate tumor nodules in the forthcoming eighth edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2016,11(5):681-692.
[16] Detterbeck F C,Franklin W A,Nicholson A G,et al.The IASLC lung cancer staging project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer[J]. J Thorac Oncol,2016,11(5):651-665.
[17] Travis W D,Asamura H,Bankier A A,et al.The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer[J]. J Thorac Oncol,2016,11(8):1204-1223.
[18] Detterbeck F C,Chansky K,Groome P,et al.The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the TNM classification of lung cancer[J].J Thorac Oncol,2016, 11(9):1433-1446.

肺癌第8版TNM分期解读与展望

Interpretation and prospect of the eighth edition of TNM staging for lung cancer

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨敏, 燕翔, 刘锡娟, 安国, 丁慧荣, 蔡英, 葛会争. 人肺癌细胞原位移植瘤小鼠模型免疫细胞的多色流式细胞术检测方法的建立[J]. 首都医科大学学报, 2023, 44(1): 99-106.
[2]	张静涛, 王欣然, 韩斌如, 强莹, 刘雪琪, 张毅. 老年肺癌患者胸腔镜肺切除术后并发心律失常的临床特征及危险因素分析[J]. 首都医科大学学报, 2022, 43(4): 564-569.
[3]	谭晓刚, 张毅. 新辅助免疫治疗在可切除非小细胞肺癌中的应用前景[J]. 首都医科大学学报, 2021, 42(5): 862-867.
[4]	王巍伟, 王珊珊, 张曼. Kininogen 1在非小细胞肺癌体液和组织中的表达及临床意义[J]. 首都医科大学学报, 2021, 42(1): 77-82.
[5]	李胜鳌, 李琦, 曹春婕, 董洪瑜, 李杰, 张秋奂, 王京源, 华海琴, 王志群. 多层螺旋CT低剂量扫描在CT引导下氩氦刀治疗肺癌时的应用价值[J]. 首都医科大学学报, 2018, 39(2): 185-189.
[6]	谭晓刚, 王若天, 姚舒洋, 支修益. XRCC1基因Arg280His多态与肺癌易感性关系的Meta分析[J]. 首都医科大学学报, 2016, 37(6): 758-762.
[7]	胡牧, 张毅, 许庆生, 刘宝东, 苏雷, 王若天, 支修益. 早期非小细胞肺癌切除范围的临床研究[J]. 首都医科大学学报, 2016, 37(6): 763-766.
[8]	潘守强, 张毅. 肺上叶前段占位性病变性质判定相关因素分析[J]. 首都医科大学学报, 2016, 37(6): 767-772.
[9]	姚舒洋, 支修益. 非小细胞肺癌术后辅助EGFR-TKI的治疗进展[J]. 首都医科大学学报, 2016, 37(6): 773-776.
[10]	孙剑, 靳松, 赵宏颖, 刘洋, 金木兰, 邢念增, 牛亦农. 5-α还原酶的表达与前列腺癌生物学行为相关性研究[J]. 首都医科大学学报, 2016, 37(3): 307-312.
[11]	支修益, 姚舒洋. 肿瘤标志物在肺癌患者管理中的研究进展[J]. 首都医科大学学报, 2015, 36(6): 986-991.
[12]	张毅, 支修益. 微创外科手术治疗早期肺癌[J]. 首都医科大学学报, 2015, 36(6): 992-997.
[13]	姚舒洋, 王鑫, 李小雪, 张毅, 支修益. 非小细胞肺癌首发骨转移患者的临床特征、治疗及预后分析[J]. 首都医科大学学报, 2015, 36(4): 533-536.
[14]	谭晓刚, 支修益. MicroRNA与非小细胞肺癌[J]. 首都医科大学学报, 2015, 36(4): 519-524.
[15]	刘宝东. 高危早期周围型非小细胞肺癌的治疗选择:亚肺叶切除、立体定向消融放射治疗、还是射频消融?[J]. 首都医科大学学报, 2015, 36(4): 537-543.